Two different studies reported that eotaxin-3 was highly elevated in serum samples of active EGPA patients and correlated highly significantly with eosinophil counts, total immunoglobulin E (IgE) levels, and acute-phase parameters. This evidence concerns the gene CCL26 and eosinophilic granulomatosis with polyangiitis.